PUBLICATION
            Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis
- Authors
- Fu, C.W., Tsai, H.E., Chen, W.S., Chang, T.T., Chen, C.L., Hsiao, P.W., Li, W.S.
- ID
- ZDB-PUB-210101-1
- Date
- 2020
- Source
- Journal of medicinal chemistry 64(1): 527-542 (Journal)
- Registered Authors
- Keywords
- none
- MeSH Terms
- 
    
        
        
            
                - Animals, Genetically Modified
- Isoenzymes/antagonists & inhibitors*
- Humans
- Sialyltransferases/antagonists & inhibitors*
- Sialyltransferases/metabolism
- Integrins/metabolism
- Phosphorylation
- Focal Adhesion Protein-Tyrosine Kinases/metabolism
- Catalysis
- Zebrafish
- Signal Transduction/drug effects
- Cell Line, Tumor
- Female
- Breast Neoplasms/pathology*
- Neoplasm Metastasis/prevention & control*
- Talin/metabolism
- NF-kappa B/metabolism
- Animals
- Enzyme Inhibitors/pharmacology*
- Paxillin/metabolism
- Glycoproteins/metabolism
- Molecular Docking Simulation
 
- PubMed
- 33371679 Full text @ J. Med. Chem.
            Citation
        
        
            Fu, C.W., Tsai, H.E., Chen, W.S., Chang, T.T., Chen, C.L., Hsiao, P.W., Li, W.S. (2020) Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis. Journal of medicinal chemistry. 64(1):527-542.
        
    
                
                    
                        Abstract
                    
                    
                
                
            
        
        
    
        
            
            
 
    
    
        
    
    
    
        
                We report the synthesis and evaluation of a series of cell-permeable and N- versus O-selective sialyltransferase inhibitors. Inhibitor design entailed the functionalization of lithocholic acid at C(3) and at the cyclopentane ring side chain. Among the series, FCW34 and FCW66 were shown to inhibit MDA-MB-231 cell migration as effectively as ST3GALIII-gene knockdown did. FCW34 was shown to inhibit tumor growth, reduce angiogenesis, and delay cancer cell metastasis in animal models. Furthermore, FCW34 inhibited vessel development and suppressed angiogenic activity in transgenic zebrafish models. Our results provide clear evidence that FCW34-induced sialyltransferase inhibition reduces cancer cell metastasis by decreasing N-glycan sialylation, thus altering the regulation of talin/integrin/FAK/paxillin and integrin/NFκB signaling pathways.
            
    
        
        
    
    
    
                
                    
                        Genes / Markers
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Expression
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Phenotype
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mutations / Transgenics
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Human Disease / Model
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Sequence Targeting Reagents
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Fish
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Orthology
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Engineered Foreign Genes
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mapping
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    